EP12.01-10 Predictors of Poor Outcomes Among Patients Receiving 1st-Line Osimertinib for Advanced EGFR Mutated Non-Small Cell Lung Cancer

F. Desland, B.G. Fitzgerald, R.S. Sheppard, G. Van Hyfte, M. Shimkus,N.C. Rohs,R. Veluswamy,C.D. Rolfo,T.U. Marron,C.B. Smith,J.E. Gomez, D.B. Doroshow

Journal of Thoracic Oncology(2023)

引用 0|浏览10
暂无评分
关键词
egfr,lung cancer,st-line,non-small
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要